Hospitalization for COVID‐19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population – a Danish cohort study

Study found increased risk of being hospitalised for COVID‐19 in pts treated with systemic corticosteroids and cyclosporine/tacrolimus vs general population (adjusted OR 1.64 and 4.75, respectively) although unknown if risk related to drug, underlying condition, or other factors.

British Journal of Clinical Pharmacology